reported that NS3’s antiproliferative effect is p53‐independent, our findings reveal that NS3 downregulates p53 and p21 expression via the circ_0001175/miR‐130a‐5p/MDM4 pathway, thereby facilitating HCC cell proliferation and metastasis. Here, KRAS is linked to hepatocellular carcinoma.